Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 2/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.41 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.41 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.40 |
| ▸ | BCHE | P06276 | 3/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28772993 | 1.00 | S1PR1 (0.41) | S1PR1S1PR3S1PR5S1PR4BCHE | |
| SCHEMBL10527688 | 1.00 | S1PR1 (0.41) | S1PR1S1PR3S1PR5S1PR4BCHE | |
| SCHEMBL9555188 | 1.00 | S1PR1 (0.41) | S1PR1S1PR3S1PR5S1PR4BCHE | |
| SCHEMBL456427 | 0.98 | S1PR1 (0.40) | S1PR1S1PR3S1PR5S1PR4BCHE | |
| SCHEMBL9357045 | 0.98 | S1PR1 (0.39) | S1PR1S1PR3S1PR5S1PR4BCHE | |
| SCHEMBL9357038 | 0.98 | S1PR1 (0.39) | S1PR1S1PR3S1PR5S1PR4BCHE | |
| SCHEMBL8893018 | 0.93 | S1PR1 (0.36) | S1PR1S1PR3S1PR5S1PR4L3MBTL1 | |
| SCHEMBL8893030 | 0.93 | S1PR1 (0.36) | S1PR1S1PR3S1PR5S1PR4L3MBTL1 | |
| Palmitamide SCHEMBL1072214 | 0.92 | MEN1 (0.40) | S1PR1S1PR3S1PR5S1PR4BCHE | |
| SCHEMBL949468 | 0.89 | L3MBTL1 (0.36) | S1PR1S1PR3S1PR5S1PR4L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2968108-A1 | COSMETIC COMPOSITIONS | Mary Kay, Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014159238-A1 | COSMETIC COMPOSITIONS | MARY KAY INC. (US) | 2014-10-02 | — | — | WO | claimed |
| US-20140271525-A1 | COSMETIC COMPOSITIONS | MARY KAY INC. (US) | 2014-09-18 | — | — | US | claimed |
| EP-2616169-A2 | CHROMATOGRAPHY MEMBRANES FOR THE PURIFICATION OF CHIRAL COMPOUNDS | Natrix Separations Inc. (CA) | 2013-07-24 | — | — | EP | claimed |
| WO-2012037101-A2 | CHROMATOGRAPHY MEMBRANES FOR THE PURIFICATION OF CHIRAL COMPOUNDS | NATRIX SEPARATIONS INC. (CA) | 2012-03-22 | — | — | WO | claimed |
| US-20120064601-A1 | Chromatography Membranes for the Purification of Chiral Compounds | NATRIX SEPARATIONS INC. (CA) | 2012-03-15 | — | — | US | claimed |
| US-12564551-B2 | Composition or oat extract comprising avenanthramide and β-glucan | SYMRISE AG (DE) | 2026-03-03 | — | — | US | disclosed |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | SYMRISE AG (DE) | 2026-02-12 | — | — | US | disclosed |
| US-20250270182-A1 | Composition Comprising an Antimicrobial Agent and an Alkyl Ketal Ester Compound | SYMRISE AG (DE) | 2025-08-28 | — | — | US | disclosed |
| US-20250255833-A1 | Compositions Comprising One or More (Bio)-Alkanediols with Antioxidants | SYMRISE AG (DE) | 2025-08-14 | — | — | US | disclosed |
| US-12350357-B2 | Active agents for skin and hair care with physicochemical modifying properties | SYMRISE AG (DE) | 2025-07-08 | — | — | US | disclosed |
| US-12303468-B2 | Compositions comprising one or more (bio)-alkanediols with antioxidants | SYMRISE AG (DE) | 2025-05-20 | — | — | US | disclosed |
| US-20250143988-A1 | COMPOSTITION WITH STABILIZED TASTE AND ODOR | SYMRISE AG (DE) | 2025-05-08 | — | — | US | disclosed |
| WO-2012037101-A2 | CHROMATOGRAPHY MEMBRANES FOR THE PURIFICATION OF CHIRAL COMPOUNDS | NATRIX SEPARATIONS INC. (CA) | 2012-03-22 | — | — | WO | disclosed |
| US-20120064601-A1 | Chromatography Membranes for the Purification of Chiral Compounds | NATRIX SEPARATIONS INC. (CA) | 2012-03-15 | — | — | US | disclosed |
| US-20110104089-A1 | COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND NEOPENTYL GLYCOL DIISONONANOATE | SYMRISE AG (DE) | 2011-05-05 | — | — | US | disclosed |
| US-20110091404-A1 | COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND COMPRISING CETYL NONANOATE AND/OR STEARYL NONANOATE | SYMRISE AG (DE) | 2011-04-21 | — | — | US | disclosed |
| US-20110034486-A1 | USE OF PTEROCARPANS AS ACTIVE ANTI-CELLULITE INGREDIENTS | SYMRISE GMBH & CO., KG (DE) | 2011-02-10 | — | — | US | disclosed |
| US-20100196504-A1 | SYNERGISTIC ACTIVE PREPARATIONS COMPRISING 1,2-DECANEDIOL AND FURTHER ANTIMICROBIAL ACTIVE COMPOUNDS | SYMRISE GMBH & CO. KG (DE) | 2010-08-05 | — | — | US | disclosed |
| US-20090306154-A1 | SYNERGISTIC ANTI-MICROBIAL MIXTURES OF TROPOLONE (DERIVATIVES) AND SELECTED COMPOUNDS | SYMRISE GMBH & CO., KG (DE) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250255833-A1 | Compositions Comprising One or More (Bio)-Alkanediols with Antioxidants | MMP8, CXCL8, IL18 | S1PR1 2517/4885S1PR3 2274/4885S1PR5 3548/4885 |
| US-20250270182-A1 | Composition Comprising an Antimicrobial Agent and an Alkyl Ketal Ester Compound | GK, DAGLA, KAT5 | S1PR1 1483/4885S1PR3 1181/4885S1PR5 780/4885 |
| US-20100196504-A1 | SYNERGISTIC ACTIVE PREPARATIONS COMPRISING 1,2-DECANEDIOL AND FURTHER ANTIMICROBIAL ACTIVE COMPOUNDS | DDT, CUTA, DPM1 | S1PR1 1199/4885S1PR3 2105/4885S1PR5 2255/4885 |
| US-12564551-B2 | Composition or oat extract comprising avenanthramide and β-glucan | CUTA, HLA-A, OAT | S1PR1 2034/4885S1PR3 2179/4885S1PR5 2836/4885 |
| US-12303468-B2 | Compositions comprising one or more (bio)-alkanediols with antioxidants | MMP8, CXCL8, IL18 | S1PR1 2517/4885S1PR3 2274/4885S1PR5 3548/4885 |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | TLR7, MYC, ERG28 | S1PR1 4144/4885S1PR3 3842/4885S1PR5 4166/4885 |
| US-20140271525-A1 | COSMETIC COMPOSITIONS | SGMS1, SGMS2, ITCH | S1PR1 132/4885S1PR3 82/4885S1PR5 59/4885 |
| US-20250143988-A1 | COMPOSTITION WITH STABILIZED TASTE AND ODOR | TAS2R16, TAS2R8, FFAR2 | S1PR1 81/4885S1PR3 91/4885S1PR5 267/4885 |
| US-20090306154-A1 | SYNERGISTIC ANTI-MICROBIAL MIXTURES OF TROPOLONE (DERIVATIVES) AND SELECTED COMPOUNDS | CBR3, MTPN, UTRN | S1PR1 3838/4885S1PR3 2920/4885S1PR5 4320/4885 |
| US-20110034486-A1 | USE OF PTEROCARPANS AS ACTIVE ANTI-CELLULITE INGREDIENTS | FABP4, PLIN1, CPT1B | S1PR1 939/4885S1PR3 1080/4885S1PR5 2286/4885 |
| US-20110091404-A1 | COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND COMPRISING CETYL NONANOATE AND/OR STEARYL NONANOATE | CUTA, FHIT, FAM83A | S1PR1 980/4885S1PR3 524/4885S1PR5 384/4885 |
| US-20110104089-A1 | COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND NEOPENTYL GLYCOL DIISONONANOATE | CUTA, KIT, DEGS1 | S1PR1 2328/4885S1PR3 2133/4885S1PR5 1115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.